Author:
Li Shuya,Yin Ke,Wang Yiwu,Tan Lihong,Zhao Jianing,Pan Shuxiang,Yang Lin,He Dan
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. National Pharmacopoeia Commission (2020) Chinese Pharmacopoeia. China Medical Science and Technology Press, p 1014
2. Ding YW, Zeng LJ, Li RF, Chen QY, Zhou BX, Chen QL, Cheng PL, Wang YT, Zheng JP, Yang ZF, Zhang FX (2017) The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complement Altern Med 17(1):130
3. Liu T, Lin S (2024) Comprehensive characterization of the chemical constituents of Lianhua Qingwen capsule by ultra high performance liquid chromatography coupled with Fourier transform ion cyclotron resonance mass spectrometry. Heliyon 10(6):27352
4. Wang YX, Zhang KY, Huang JH, Han SL, Zhao JH, Xu ZJ (2013) Clinical drug safty of lianhuaqingwen preparation: A systematic evaluation. Evaluation and Analysis of Drug-Use in Hospitals of China 13(8):676–681
5. Zhuang W, Fan Z, Chu YQ, Wang HZ, Yang Y, Wu L, Sun N, Sun G, Shen YQ, Lin XL, Guo GM, Xi SY (2020) Chinese patent medicines in the treatment of coronavirus disease 2019 (COVID-19) in China. Front Pharmacol 11:1066